- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Close a sale effectively
Helping the customer to a buying decision means uncovering motivators and providing justification for investing in your product over the alternatives.
Closing is not a series of manipulative phrases or word tricks aimed at clinching the deal. Helping the customer to a buying decision means uncovering motivators and providing justification for investing in your product over the alternatives. You can learn to be a better closer by educating yourself on your products and competition.
There are six steps in delivering a highly professional closing sequence:
1. Recommend the product you feel is most appropriate for the customer. Back up your recommendation with an explanation, such as a recap of key features and benefits. Be sure to use the words, "I recommend." This will help you sound more like a consultant than a salesperson.
2. Ask your customers if they have any additional questions or need more information.
3. Describe where your product is available.
4. Explain reimbursement and cost considerations for the product.
5. Ask which treatment option is most suited to their patient needs.
6. Complete the paperwork for sample processing and seek the customer's agreement to prescribe your product.
If you have done a good job developing your sales presentation, you should be able to move with confidence into this effective, assumptive close. It will lead to the most natural and comfortable end of a sales call you can have. PR
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
